The Weight Loss Drug Acomplia

Dr. Susan Sharma: This is insidermedicine in 60. From Cleveland, the weight loss drug Acomplia may alter certain risk factor for heart disease but doesn't appear to reverse it where researchers randomized over 800 patients required an angiogram to receive either Acomplia or placebo, is the intravascular ultrasound, no differences were noted in those received for the two treatments. Those received Acomplia lost more weight and had a greater reduction in triglycerides or also more likely to develop psychiatric symptoms.

From Texas, the American Heart Association has officially recognized that hands only CPR, a technique in which no breathes are administered and instead 100 compressions per minute are delivered is superior to the traditional technique. The traditional tradition technique is still recommended for children given that a collapse in a child is more likely due to breathing problem.

And finally from Hamilton, a newer class of blood pressure lowering medications known as ARBs may have a better safety profile than the older ones. A trail of over 25,000 patients with heart disease will randomize to receive an ARB and ACE inhibitor or both. Those who received an ARB or an ACE inhibitor had an equal lowering effect on blood pressure but those who receive the ARB were less likely to experience side effects. For insidermedicine in 60, I am Dr. Susan Sharma.


Transcription by: Scribe4you Transcription Services